EVALUATION OF THE APTT (ACTIVATED PARTIAL THROMBOPLASTIN TIME) INDEX IN FREEZE-DRIED PLASMA APPLICATION FOR EXTERNAL PROGRAM FOR COAGULATION CONTROL

Thị Hồng Nguyễn, Thị Thùy Trang Lê, Khánh Cường Nguyễn, Tiến Huỳnh Nguyễn, Nhật Nguyên Trần, Thanh Tùng Lê, Văn Chương Lê, Đức Thắng Nguyễn, Thanh Tùng Trần, Thị Thảo Nguyễn, Quang Huy Vũ

Main Article Content

Abstract

Objective: Research to evaluate the uniformity and stability of the aPTT (Activated Partial Thromboplastin Time) index in freeze-dried plasma applied to the coagulation external control program according to ISO 13528:20151 and ISO guide 352 standards. Methods: Experimental research. Fresh frozen plasma provided by Ho Chi Minh City Blood Transfusion Hematology Hospital was screened negative for HBV, HCV, HIV, malaria, and syphilis. One-way ANOVA was used to evaluate the homogeneity and stability of freeze-dried plasma over different time points and temperatures using the t-test. Results: Lyophilized plasma containing the aPTT index achieved uniformity that met the proficiency testing program with p > 0.05. Lyophilized plasma containing aPTT index is stable when stored at temperatures of 2-80C and -200C for up to 3 months and is stable for transportation for a maximum of 7 days. Conclusion: Lyophilized plasma containing the aPTT index achieved uniformity that met the proficiency testing program with p > 0.05. Lyophilized plasma containing the APTT index is stable when stored at temperatures of 2-80C and -200C for up to 3 months and is stable for transportation for up to 7 days according to the criteria of ISO 13528:2015 and ISO guide 35 responses to the external audit program

Article Details

References

International Standard Organization (2015). "ISO 13528 Statistical methods for use in proficiency testing by interlaboratory comparison”, Geneva, Switzerland, First edition.
2. International Organization for Standardization. (2017). ISO Guide 35: Reference materials — Guidance for characterization and assessment. Geneva: ISO.
3. Cunningham MT, et al. Quality assurance in hemostasis:the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost. Apr 2007;33(3): 250-8.
4. Jones P. Haemophilia: a global challenge. Haemophilia. Jan 1995;1(1):11-3.
5. Yuan H, Gao Z, Zhang J, et al. Homogeneity and Stability Evaluation of External Quality Assessment Control Materials for Four Coagulation Tests. Clin Lab. May 1 2021;67(5).
6. Rao L, Okorodudu A, Petersen J, et al. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clinica chimica acta. 2000;300(1-2):13-21.
7. Bux J, Dickhörner D, Scheel E. Quality of freeze-dried (lyophilized) quarantined single-donor plasma. Transfusion. Dec 2013;53(12): 3203-9. doi:10.1111/trf.12191
8. Woodhams B, Girardot O, Blanco MJ, et al. Stability of coagulation proteins in frozen plasma.Blood Coagul Fibrinolysis. Jun 2001;12(4): 229-36.doi:10.1097/00001721-200106000-00002
9. Marlar RA, Clement B, Gausman J. Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations. Thieme Medical Publishers; 2017:253-260.
10. Jennings I, Kitchen D, Woods T, et al. Stability of coagulation proteins in lyophilized plasma. International Journal of Laboratory Hematology.2015;37(4):495-502.